The Quantitative Imaging for Personalized Cancer Medicine
(QIPCM) program provides a  host of services, which include imaging data de-identification and transfer, centralized storage with remote access, imaging protocol development, novel image analysis tools development, as well as imaging data curation and feature extraction for large-scale imaging research studies.

Photo of the QIPCM Team


Help simplify the workflow for de-identification, transfer, and centralized image collection.

Theranostics & Molecular Imaging Support

Provide support through the development of customize dosimetry tools and molecular imaging analysis.

Image Analysis & Research Support

Assist studies in quantitative analysis as well as custom tool development.

QIPCM Radiomics

We have tools to support radiomics feature extraction, meta-data curation, and data curation.

On-going Projects

OICR Adaptive Oncology

QIPCM is a part of the imaging program under the adaptive oncology initiative. AO is an important research arm of OICR that focuses on 2 key goals: detecting cancer early and find the right treatment at the right time.


Ontario-wide Cancer Targeted Nucleic Acid Evaluation (Clinicaltrials.gov identifier: NCT02906943). PIs: Dr. Philippe Bedard and Dr. Benjamin Haibe-Kains. QIPCM has been collecting the multi-centre radiology imaging, integrating the QIPCM webviewer into the platform, providing the infrastructure and tools to enable and guide image contouring by board-certified clinicians, and enabling radiomic analysis of contoured images.


Machine learning in medical imaging consortium. The purpose of the Consortium is to expedite the advancement of machine learning solutions for unaddressed requirements in medical imaging. This is achieved through collaborative efforts involving academic and clinical researchers, as well as Canadian industry partners.
Visit the MaLMIC – Machine Learning in Medical Imaging Consortium Website


QIPCM is actively involved in the radiotheranostics activities within UHN most notably in leading the development of the dosimetry workflow utilized for the OZM-067 NET-PRRT trial which has been adapted for standard of cancer Lutathera imaging at the Princess Margaret Cancer Centre. This workflow can be used for a wide range of radiotheranostics agents (including 177Lu-PSMA) as need arises.
Theranostics – University Health Network

Automated Image and Metadata Quality Assurance

QIPCM has developed a new automated image and metadata QA tool for improving efficiency in our quality assurance workflow while increasing error detection accuracy. The tool checks metadata for both study deviations (image misregistration or missing slices) and possible PHI, in an automated approach that is unfeasible manually.

OHIF webviewer

QIPCM is collaborating with the Open Health Imaging Foundation (OHIF) Open Health Imaging Foundation (ohif.org). We provide our user with access to OHIF’s open-source, lightweight and cost-effective web-based medical imaging viewer. We receive guidance from OHIF in developing new features which would further enhance our users experience and support them towards imaging research and education

Links to other place for information of the program/team:

Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

Click to enable/disable Google Analytics tracking code.
Click to enable/disable Google Fonts.
Click to enable/disable Google Maps.
Click to enable/disable video embeds.
Our website uses cookies, mainly from 3rd party services. Define your Privacy Preferences and/or agree to our use of cookies.